Biotecnología

Biotecnología

BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in Africa
24/06/2022 - Facility will be initially equipped with two BioNTainers, and is expected to employ about 100 staff by 2024.
Cullinan Oncology, Taiho to Develop & Commercialize CLN-081/TAS6417 in the U.S.
24/06/2022 - Will equally share future profits in the U.S.
Avantor, GeminiBio Partner on Custom Hydrated Solutions and Cell Culture Media
24/06/2022 - Aims to support growth of emerging modalities by offering custom cGMP solutions to enhance process efficiency and accelerate time-to-market.
Antheia Receives $40 million in Venture Debt Financing
24/06/2022 - Announces plans to construct a new pilot scale biomanufacturing facility.
Desarrollan un biomarcador que permitirá tratar de forma eficaz los cánceres más graves
23/06/2022 - Un nuevo estudio, publicado esta semana en la revista Nature, proporciona una serie...
Galapagos to Acquire CellPoint and AboundBio
23/06/2022 - Gains scalable, decentralized and automated point-of-care cell therapy supply model and next-gen fully human antibody-based therapeutics platform.
FDA Approves Merck’s Vaxneuvance in Infants and Children
23/06/2022 - Becomes the first pneumococcal conjugate vaccine approved in almost a decade to help protect pediatric populations.
Piramal Pharma Solutions Appoints Herve Berdou as Chief Operating Officer
22/06/2022 - Brings 25 years of global operations and supply chain experience to the new role.
Sanofi
22/06/2022
Pfizer
22/06/2022
Novartis
22/06/2022
ChargePoint Technology Expands in Europe
22/06/2022 - New facility near Munich will support customers in the DACH region.
Waters and BioInfra Establish the ASEAN Academy for Bioanalysis
22/06/2022 - Companies collaborate to promote development of bioanalytical skills with joint opening of the ASEAN Academy for Bioanalysis in South Korea.
OrganaBio Begins GMP Manufacturing Operations
22/06/2022 - The cell therapy CDMO offers access to flexible manufacturing solutions and clinical grade cellular raw materials.
New Agreement Paves Way for Development of First African-owned COVID-19 Vaccine
22/06/2022 - Afrigen and Univercells enter a new agreement to develop the first African-own COVID-19 vaccine.
OSE Immunotherapeutics, Microsoft Enter Research and Technology Collaboration
21/06/2022 - OSE to further develop its digital tools in AI and algorithmic approaches for the development of first-in-class immunotherapies.
Humanigen, PCI Pharma Services Enter Lenzilumab Partnership
21/06/2022 - PCI to provide importation, release and commercialization services in the UK for investigational COVID treatment lenzilumab.
Pfizer to Invest $95 Million in Valneva
21/06/2022 - Funds will further support the strategic Lyme partnership between the two companies.
OrganaBio Launches Contract Cell Therapy Manufacturing Ops
21/06/2022 - To provide custom contract-, self-, and hybrid-manufacturing options for therapeutics developers.
Abbvie’s SKYRIZI FDA-Approved as First IL-23 to Treat Crohn's Disease
21/06/2022 - As early as week 4, clinical response and clinical remission were achieved by significantly more subjects treated with SKYRIZI versus placebo.